MedAdvisor Stock

MedAdvisor EPS Growth

Delisted

The EPS Growth of MedAdvisor (MDR.AX) as of Aug 23, 2026 is -2,504.65 %. In the previous year, EPS Growth was 79.33 % — a change of -3,257.38% (lower).

EPS Growth

-2,504.65 %

YoY

-3,257.38%

Last updated:

EPS Growth of MedAdvisor is 2026 -2,504.65 % . EPS Growth of MedAdvisor was 2025 79.33 % . It decreases by -3,257.38% lower compared to the previous year.

The MedAdvisor EPS Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS Growth
Date
EPS Growth
Jan 1, 2018
-538.91 AUD
Jan 1, 2019
76.27 AUD
Jan 1, 2020
0.96 AUD
Jan 1, 2021
-6.78 AUD
Jan 1, 2022
-4.08 AUD
Jan 1, 2023
54.68 AUD
Jan 1, 2024
79.33 AUD
Jan 1, 2025
-2,504.65 AUD
The MedAdvisor EPS Growth history
YEAREPS GrowthYoY
-2,504.65 %-3,257.38%
79.33 %+45.06%
54.68 %-1,439.76%
-4.08 %-39.80%
-6.78 %-806.78%
0.96 %-98.74%
76.27 %-114.15%
-538.91 %-2,063.91%
27.44 %-103.70%
-742.22 %-865.18%
97.00 %—
Access this data via the Eulerpool API
Get Free API Key

MedAdvisor Stock analysis

What does MedAdvisor do? Medadvisor Ltd is an Australian company that offers a digital platform for healthcare. Founded in 2012 by Robert Read, David Liu, and Josh Swinnerton, their aim was to develop a platform that simplifies medication management for patients, pharmacies, and doctors. Today, Medadvisor is a publicly traded company with a wide range of digital healthcare solutions. They offer various solutions to support patients in medication intake and management, such as a mobile application that allows patients to manage their medications, order prescriptions, and receive reminders. They also offer solutions for pharmacies, including an online ordering system and access to electronic patient history, as well as a platform for doctors to electronically issue prescriptions. One of their latest products is a mobile application that facilitates the handling of COVID-19, providing real-time virus spread tracking and symptom tracking tools. Medadvisor focuses on meeting customer needs and continuously improving the healthcare process. They recently partnered with Take2 Healthcare to expand their range of solutions and create the best offering of health solutions. Overall, Medadvisor plays an important role in the Australian healthcare system by helping their customers live happier and healthier lives through innovative technologies and services. MedAdvisor is one of the most popular companies on Eulerpool.

Frequently Asked Questions about MedAdvisor stock

EPS Growth of MedAdvisor is -2,504.65 % in 2026.

On Eulerpool you can find the complete historical development of EPS Growth MedAdvisor since 2006 – with annual values, charts, and detailed analysis.

EPS growth measures the percentage change in earnings per share. It accounts for both profit changes and share count changes.

To evaluate EPS Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EPS Growth.

EPS Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EPS Growth's MedAdvisor historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Growth — MedAdvisor

Revenue GrowthRevenue CAGR 3YRevenue CAGR 5YRevenue CAGR 10YEarnings GrowthEPS GrowthEBIT GrowthEBIT CAGR 3YEBIT CAGR 5YEBIT CAGR 10YDividend GrowthFCF GrowthBook Value GrowthEarnings CAGR 3YEarnings CAGR 5YEarnings CAGR 10YEPS CAGR 3YEPS CAGR 5YEBITDA Growth YoYEBITDA CAGR 3YEBITDA CAGR 5YGross Profit GrowthOCF Growth YoYEmployee GrowthDividend CAGR 3YDividend CAGR 5YDividend CAGR 10YAsset GrowthEquity GrowthDebt GrowthCapEx GrowthFCF CAGR 3YFCF CAGR 5YMarket Cap GrowthShare Count Growth

All Key Metrics — MedAdvisor